The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CEL-SCI Corporation(NYSE MKT:CVM) 
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antig...
CEL-SCI Days Payable Outstanding ttm (DPO)
CEL-SCI Days Inventory Outstanding ttm (DIO)
CEL-SCI Op Cashflow Per Share ttm
CEL-SCI Free Cashflow Per Share ttm
CEL-SCI Cash Per Share ttm
CEL-SCI (GAAP) P/E ratio ttm
CEL-SCI P/B ratio ttm
No extra charts and metrics for this ticker.